Cyhono-Pharmaceutical seishemal anti-peptides for injection seisido approved
-
Last Update: 2020-06-16
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Drug Indications: Treatment of advanced solid tumors, such as lung, bowel, stomach, etcResearch: After the company obtained the approval, actively promote pharmaceutical and clinical work, has officially launched the Phase I clinical trial workSimilar drug market conditions: In 2004, the first antivascular-generated antibody drug belavite was introduced in the United States for the treatment of metastatic colon cancer and moreThe experiments on angiogenesis anti-peptide efficacy showed that different doses of angiogenesis peptides had inhibitory effectonon on the growth of gastric cancer cells BGC-823, lung cancer cells PG and bowel cancer cells HT-29, and also inhibited the almanocre cell B16F10 lung metastasis.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
